December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia
Dec 7, 2024, 02:54

Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia

Jonathan Friedberg, Director of Wilmot Cancer Institute, shared a recent article by Petra Langerbeins on X:

“Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: Phase III CLL12 Trial shows watch and wait still remains the standard. Journal of Clinical Oncology and The SWOG Cancer Research Network, S1925 trial is asking a similar question with venetoclax.”

Title: Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial

Authors: Petra Langerbeins, Sandra Robrecht, Pascal Nieper, Paula Cramer, Moritz Fürstenau, Othman Al-Sawaf,Florian Simon, Anna-Maria Fink, Karl-Anton Kreuzer, Ursula Vehling-Kaiser, Eugen Tausch, Christof Schneider, Lothar Müller, Michael Josef Eckart, Rudolf Schlag, Werner Freier, Tobias Gaska, Christina Balser, Marcel Reiser, Martina Stauch, Mark-Oliver Zahn, Steffen Dörfel, Peter Staib, Timo Behlendorf, Manfred Hensel, Holger Hebart, Holger Klaproth, Andreas Block, Rüdiger Liersch, Ulrich Hauch, Bernhard Heinrich, Clemens-Martin Wendtner, Kirsten Fischer, Stephan Stilgenbauer, Barbara Eichhorst and Michael Hallek

Chronic Lymphocytic Leukemia

For more updates, follow OncoDaily.